Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Healthcare 892 Financials 884 Information Technology 517 Industrials 386 Consumer Discretionary 320 Communication Services 200 Consumer Staples 114 Materials 78 Energy 67 Real Estate 64 Utilities 27

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 471 Pharmaceuticals 159 Healthcare Equipment & Supplies 138 Healthcare Providers & Services 61 Life Sciences Tools & Services 38 Health Care Technology 25
Industry stocks

Biotechnology Stocks on NASDAQ

Compare NASDAQ-listed Biotechnology stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

Celcuity LLC (CELC)
Fair Value-42.7% Downside Overvalued Analyst76.0% Upside Market Cap4.51 B P/E-23.5x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Cellectis SA (CLLS)
Fair Value14.5% Upside Fair Analyst172.4% Upside Market Cap208.3 M P/E-3.1x Yield0.0% HealthFair
  NASDAQ
Cogent Biosciences Inc (COGT)
Analyst28.3% Upside Market Cap7.322 B Yield0.0% HealthFair
  NASDAQ
Collplant Biotechnologies Ltd (CLGN)
Fair Value-2.4% Downside Fair Market Cap5.423 M P/E-0.4x Yield0.0% HealthWeak
  NASDAQ
Corbus Pharmaceuticals Holding (CRBP)
Fair Value0.4% Upside Fair Analyst268.9% Upside Market Cap174.2 M P/E-2.1x Yield0.0% HealthFair
  NASDAQ
Corvus Pharmaceuticals Inc (CRVS)
Fair Value-26.1% Downside Overvalued Analyst138.0% Upside Market Cap1.171 B P/E-26.5x Yield0.0% HealthGood
  NASDAQ Featured in Small-Cap Stocks
Crispr Therapeutics AG (CRSP)
Fair Value-21.6% Downside Overvalued Analyst66.2% Upside Market Cap5.131 B P/E-11.2x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Cue Biopharma (CUE)
Fair Value15.0% Upside Fair Analyst333.6% Upside Market Cap111.7 M P/E-5.7x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Cypherpunk Technologies Inc (CYPH)
Fair Value-18.7% Downside Overvalued Analyst22.8% Upside Market Cap73.46 M P/E-1.4x Yield0.0% HealthFair
  NASDAQ
CytomX Therapeutics Inc (CTMX)
Fair Value-18.7% Downside Overvalued Analyst273.1% Upside Market Cap722.8 M P/E-11.7x Yield0.0% HealthGood
  NASDAQ Featured in Small-Cap Stocks
DBV Technologies (DBVT)
Fair Value-15.6% Downside Fair Analyst189.3% Upside Market Cap830.6 M P/E-4.7x Yield0.0% HealthWeak
  NASDAQ Featured in Small-Cap Stocks
Decoy Therapeutics Inc (DCOY)
Fair Value53.3% Upside Bargain Analyst616.0% Upside Market Cap2.325 M P/E-0.2x Yield0.0% HealthWeak
  NASDAQ
Denali Therapeutics Inc (DNLI)
Fair Value-38.3% Downside Overvalued Analyst40.5% Upside Market Cap3.836 B P/E-7.6x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Editas Medicine Inc (EDIT)
Fair Value-1.6% Downside Fair Analyst117.4% Upside Market Cap425.1 M P/E-3.9x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Ensysce Biosciences Inc (ENSC)
Fair Value20.9% Upside Undervalued Market Cap5.646 M P/E-0.5x Yield0.0% HealthWeak
  NASDAQ
Entera Bio Ltd (ENTX)
Fair Value-24.7% Downside Overvalued Analyst220.3% Upside Market Cap141.5 M P/E-11.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Fennec Pharmaceuticals Inc (FENC)
Fair Value12.7% Upside Fair Analyst48.9% Upside Market Cap351.2 M P/E-43.6x Yield0.0% HealthGreat
  NASDAQ Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum High-Growth Small-Cap Stocks Small-Cap Stocks
Forte Biosciences Inc (FBRX)
Fair Value-41.9% Downside Overvalued Analyst-3.7% Downside Market Cap1.872 B P/E-24.7x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks Small-Cap Stocks
Fortress Biotech Inc Pref Series A (FBIOP)
Fair Value-0.6% Downside Fair Market Cap90.356 M P/E0.8x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
Forum Markets, Inc (FRMM)
Fair Value51.8% Upside Bargain Analyst52.5% Upside Market Cap77.147 M P/E-0.2x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Genprex Inc (GNPX)
Fair Value72.9% Upside Bargain Market Cap2.127 M P/E-0.1x Yield0.0% HealthWeak
  NASDAQ
GridAI Technologies Corp (GRDX)
Market Cap18.296 M Yield0.0% HealthFair
  NASDAQ
Immunitybio Inc (IBRX)
Fair Value1.4% Upside Fair Analyst75.6% Upside Market Cap7.366 B P/E-7.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Immuron Ltd ADR (IMRN)
Fair Value34.3% Upside Undervalued Analyst258.4% Upside Market Cap7.377 M P/E-2.2x Yield0.0% HealthGood
  NASDAQ
Indaptus Therapeutics Inc (INDP)
Fair Value-33.6% Downside Overvalued Analyst651.9% Upside Market Cap154 M P/E-8.0x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
InflaRx N.V. (IFRX)
Fair Value-37.9% Downside Overvalued Analyst326.0% Upside Market Cap262.2 M P/E-5.3x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Insight Molecular Diagnostics Inc (IMDX)
Fair Value18.0% Upside Fair Analyst66.7% Upside Market Cap165.3 M P/E-3.4x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Intellia Therapeutics Inc (NTLA)
Fair Value10.3% Upside Fair Analyst136.5% Upside Market Cap1.582 B P/E-3.9x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Kala Pharmaceuticals Inc (KALA)
Fair Value12.6% Upside Fair Market Cap13.812 M P/E-0.7x Yield0.0% HealthFair
  NASDAQ
Kiniksa Pharmaceuticals Ltd (KNSA)
Fair Value-4.3% Downside Fair Analyst25.5% Upside Market Cap5.929 B P/E75.5x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth High-Momentum Stocks
Krystal Biotech Inc (KRYS)
Fair Value4.1% Upside Fair Analyst17.5% Upside Market Cap9.613 B P/E39.9x Yield0.0% HealthGreat
  NASDAQ
Kura Oncology Inc (KURA)
Fair Value5.6% Upside Fair Analyst238.4% Upside Market Cap840.7 M P/E-2.8x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
Kyntra Bio Inc (KYNB)
Fair Value26.7% Upside Undervalued Analyst457.9% Upside Market Cap28.013 M P/E-0.5x Yield0.0% HealthFair
  NASDAQ
Lunai Bioworks Inc (LNAI)
Market Cap11.561 M P/E-0.1x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Marker Therapeutics Inc (MRKR)
Fair Value70.8% Upside Bargain Analyst590.1% Upside Market Cap20.508 M P/E-1.7x Yield0.0% HealthFair
  NASDAQ
Mereo BioPharma Group PLC ADR (MREO)
Fair Value35.0% Upside Undervalued Analyst552.4% Upside Market Cap51.413 M P/E-1.4x Yield0.0% HealthWeak
  NASDAQ
Mesoblast Ltd (MESO)
Fair Value-9.0% Downside Fair Analyst133.8% Upside Market Cap1.954 B P/E-20.7x Yield0.0% HealthGood
  NASDAQ Featured in Technical Strength Leaders
MetaVia Inc (MTVA)
Fair Value21.4% Upside Undervalued Market Cap7.54 M P/E-0.6x Yield0.0% HealthWeak
  NASDAQ
Moleculin Biotech Inc (MBRX)
Fair Value46.0% Upside Undervalued Market Cap2.185 M P/E0.0x Yield0.0% HealthWeak
  NASDAQ
Mustang Bio Inc (MBIO)
Fair Value48.3% Upside Undervalued Market Cap4.501 M P/E-1.7x Yield0.0% HealthFair
  NASDAQ
Natera Inc (NTRA)
Fair Value-39.1% Downside Overvalued Analyst3.0% Upside Market Cap39.411 B P/E-173.8x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks
NuCana PLC (NCNA)
Fair Value47.1% Upside Undervalued Market Cap5.785 M P/E-0.1x Yield0.0% HealthFair
  NASDAQ
Ocugen, Inc (OCGN)
Fair Value-2.0% Downside Fair Analyst835.9% Upside Market Cap443.5 M P/E-6.1x Yield0.0% HealthWeak
  NASDAQ Featured in Small-Cap Stocks
Organogenesis Holdings Inc (ORGO)
Fair Value23.2% Upside Undervalued Analyst26.6% Upside Market Cap305 M P/E-21.0x Yield0.0% HealthGood
  NASDAQ Featured in Small-Cap Stocks
OUTLOOK THERAPEUTICS INC (OTLK)
Fair Value-21.6% Downside Overvalued Analyst424.3% Upside Market Cap179.6 M P/E-3.2x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Ovid Therapeutics Inc (OVID)
Fair Value-9.9% Downside Fair Analyst117.7% Upside Market Cap474.1 M P/E-20.3x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Palvella Therapeutics Inc (PVLA)
Fair Value-26.0% Downside Overvalued Analyst48.8% Upside Market Cap2.19 B P/E-36.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
PDS Biotechnology Corp (PDSB)
Fair Value27.5% Upside Undervalued Analyst931.6% Upside Market Cap40.187 M P/E-1.2x Yield0.0% HealthFair
  NASDAQ
ProQR Therapeutics NV (PRQR)
Fair Value3.8% Upside Fair Analyst318.8% Upside Market Cap258.3 M P/E-5.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Protagonist Therapeutics Inc (PTGX)
Fair Value-27.3% Downside Overvalued Analyst-2.9% Downside Market Cap8.734 B P/E-77.0x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
Explore listed stocks on NASDAQ with company information and fair value data.